hd17: pet guided omission of radiotherapy in hodgkin lymphoma
Published 4 years ago • 941 plays • Length 4:07Download video MP4
Download video MP3
Similar videos
-
1:34
pet-guided treatment: the new standard of care in hodgkin lymphoma?
-
1:12
optimizing treatment in hodgkin lymphoma
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl
-
0:53
the current state of mrd in hodgkin lymphoma
-
2:03
advances in pet & radiomics in lymphoma & insights into the international metabolic prognostic index
-
16:07
hodgkin's lymphoma
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
49:16
23rd masterclass lecture on hodgkin's lymphoma - current treatment strategy, wednesday 31st may
-
2:00
updates on treatment methods for hodgkin lymphoma
-
1:03
what’s on the horizon for hodgkin lymphoma?
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
2:27
predictive value of 18f-fdg-pet radiomics in r/r hodgkin lymphoma
-
1:37
the role of ctdna in hodgkin lymphoma
-
1:30
advances in the management of r/r hodgkin lymphoma
-
2:40
exploring the genomic landscape of hodgkin lymphoma with whole-genome sequencing
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
1:26
improving tools and techniques for mrd detection in hodgkin lymphoma
-
1:19
what's on the horizon for the treatment of mpns?
-
1:56
optimal therapy sequencing for hodgkin lymphoma
-
4:06
lymphoma cellular therapy update
-
1:59
hodgkin lymphoma: prognostic markers in the era of novel treatments
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml